Sustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 6, 2010, Pages 753-757

  Frolund L ^a   Durham, S R ^b   Calderon, M ^b   Emminger, W ^c   Andersen, J S ^d   Rask, P ^d   Dahl, R ^e  

^a Allergy and Lung Clinic   (Denmark)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c Allergie Ambulatorium Rennweg Vienna   (Austria)

^d ALK ABELLÓ   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Allergy immunotherapy tablet; Grass pollen allergy; Quality of life; Rhinoconjunctivitis; RQLQ(S)

Indexed keywords

GRASS POLLEN VACCINE; PLACEBO; TABLET;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EMOTION; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; SLEEP DISORDER; TREATMENT DURATION; ADMINISTRATION AND DOSAGE; CHILD; CONJUNCTIVITIS, ALLERGIC; FOLLOW UP; IMMUNOLOGY; POACEAE; POLLEN; PROCEDURES; RHINITIS, ALLERGIC, SEASONAL; TABLET; THERAPEUTIC USE;

CHILD; CONJUNCTIVITIS, ALLERGIC; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; POACEAE; POLLEN; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, SEASONAL; TABLETS;

EID: 77951934264     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02238.x     Document Type: Article

References (13)

1. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc 2007 28 : 3 9.
2. Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol 2007 120 : 381 387. (Pubitemid 47102376)
3. Vuurman EF, van Veggel LM, Uiterwijk MM, Leutner D, O'Hanlon JF. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 1993 71 : 121 126. (Pubitemid 23245942)
4. Sundberg R, Toren K, Hoglund D, Aberg N, Brisman J. Nasal symptoms are associated with school performance in adolescents. J Adolesc Health 2007 40 : 581 583. (Pubitemid 46783884)
5. Petersen KD, Kronborg C, Gyrd-Hansen D, Dahl R, Larsen JN, Lowenstein H. Quality of life in rhinoconjunctivitis assessed with generic and disease-specific questionnaires. Allergy 2008 63 : 284 291. (Pubitemid 351224679)
6. Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy 2007 62 (Suppl. 85 9 16. (Pubitemid 47561568)
7. Valovirta E, Myrseth SE, Palkonen S. The voice of the patients: allergic rhinitis is not a trivial disease. Curr Opin Allergy Clin Immunol 2008 8 : 1 9.
8. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991 21 : 77 83.
9. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999 104 (2 Pt 1 364 369. (Pubitemid 29420434)
10. Durham SR, Emminger W, Kapp A, Colombo G, de Monchy J, Rak S et al. Long-term clinical efficacy in grass pollen rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2009 in press.
11. Juniper EF, Riis B, Juniper BA. Development and validation of an electronic version of the Rhinoconjunctivitis Quality of Life Questionnaire. Allergy 2007 62 : 1091 1093. (Pubitemid 47220962)
12. Rak S, Yang WH, Pedersen MR, Durham SR. Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: a double-blind, randomised study. Qual Life Res 2007 16 : 191 201. (Pubitemid 46088353)
13. Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling H-J et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for Respiratory allergy. A statement of the World Allergy Organization (WAO) taskforce. Allergy 2007 62 : 317 324. (Pubitemid 46246497)